Literature DB >> 1008547

Antibiotic synergy and antagonism against clinical isolates of Klebsiella species.

R M D'Alessandri, D J McNeely, R M Kluge.   

Abstract

Minimal inhibitory concentrations of kanamycin, gentamicin, amikacin, cephalothin, and chloramphenicol were determined in Trypticase soy broth for 70 clinical isolates of Klebsiella species. Gentamicin and amikacin were the most active on a weight basis. Chloramphenicol was more active than kanamycin, and cephalothin was the least active of all. Studies using a microtiter modification of the checkerboard technique were performed to evaluate the comparative activity of the three aminoglycosides in combination with either chloramphenicol or cephalothin. The cephalothin-aminoglycoside combinations demonstrated synergy in >80% of the isolates tested. No antagonism was noted. The chloramphenicol-aminoglycoside combinations showed antagonism in 35 to 45% of the isolates tested. The data suggest that the chloramphenicol-aminoglycoside combinations be used with caution when treating serious infections where Klebsiella is a potential pathogen.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 1008547      PMCID: PMC429860          DOI: 10.1128/AAC.10.6.889

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  9 in total

1.  In vitro effectiveness of kanamycin and kanamycin/cephalothin against Klebsiella. Comparison with other antibiotics.

Authors:  R J Bulger
Journal:  Ann Intern Med       Date:  1967-09       Impact factor: 25.391

2.  Clinical significance of in vitro synergism between antibiotics in gram-negative infections.

Authors:  J Klastersky; R Cappel; D Daneau
Journal:  Antimicrob Agents Chemother       Date:  1972-12       Impact factor: 5.191

3.  Gram-negative rod bacteremia.

Authors:  C M Martin; A J Cuomo; M J Geraghty; J R Zager; T C Mandes
Journal:  J Infect Dis       Date:  1969 Apr-May       Impact factor: 5.226

4.  In vitro studies of BB-K8, a new aminoglycoside antibiotic.

Authors:  G P Bodey; D Stewart
Journal:  Antimicrob Agents Chemother       Date:  1973-08       Impact factor: 5.191

5.  Bactericidal effect of combinations of antibiotics on Klebsiella-Enterobacter-Serratia.

Authors:  R Luboshitzky; T Sacks; J Michel
Journal:  Chemotherapy       Date:  1973       Impact factor: 2.544

6.  Four-hour microbiological assay of gentamicin in serum.

Authors:  E Warren; R J Snyder; I I Washington JA
Journal:  Antimicrob Agents Chemother       Date:  1972-01       Impact factor: 5.191

7.  In vitro susceptibility of gram-negative bacilli to gentamicin.

Authors:  J A Washington; R E Ritts; W J Martin
Journal:  Mayo Clin Proc       Date:  1970-02       Impact factor: 7.616

8.  Bacteriological and clinical activity of the ampicillin-gentamicin and cephalothin-gentamicin combinations.

Authors:  J Klastersky; R Cappel; G Swings; L Vandenborre
Journal:  Am J Med Sci       Date:  1971-11       Impact factor: 2.378

9.  Comparative activity of tobramycin, amikacin, and gentamicin alone and with carbenicillin against Pseudomonas aeruginosa.

Authors:  R M Kluge; H C Standiford; B Tatem; V M Young; W H Greene; S C Schimpff; F M Calia; R B Hornick
Journal:  Antimicrob Agents Chemother       Date:  1974-10       Impact factor: 5.191

  9 in total
  5 in total

Review 1.  Antibiotic combinations: should they be tested?

Authors:  G M Eliopoulos; C T Eliopoulos
Journal:  Clin Microbiol Rev       Date:  1988-04       Impact factor: 26.132

2.  Brain abscess due to Streptobacillus moniliformis and Actinobacterium meyerii.

Authors:  B A Dijkmans; R T Thomeer; G J Vielvoye; A S Lampe; H Mattie
Journal:  Infection       Date:  1984 Jul-Aug       Impact factor: 3.553

3.  Early synergistic interactions between amikacin and six beta-lactam antibiotics against multiply resistant members of the family Enterobacteriaceae.

Authors:  R H Glew; R A Pavuk
Journal:  Antimicrob Agents Chemother       Date:  1984-09       Impact factor: 5.191

4.  A toxin-antitoxin module in Bacillus subtilis can both mitigate and amplify effects of lethal stress.

Authors:  Xiangli Wu; Xiuhong Wang; Karl Drlica; Xilin Zhao
Journal:  PLoS One       Date:  2011-08-29       Impact factor: 3.240

5.  Antimicrobial Drug Interactions: Systematic Evaluation of Protein and Nucleic Acid Synthesis Inhibitors.

Authors:  Kaan Yilancioglu
Journal:  Antibiotics (Basel)       Date:  2019-08-09
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.